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ANTIPHOSPHOCHOLINE ANT IBODIES  FOUND IN  NORMAL 
MOUSE SERUM ARE PROTECTIVE  AGAINST INTRAVENOUS 
INFECT ION WITH TYPE  3 STREPTOCOCCUS PNEUMONIAE*  
BY DAVID E. BRILES, MOON NAHM, KENNETH SCHROER, JOSEPH DAVIE, 
PHILLIP BAKER, JOHN KEARNEY, AND RAUL BARLETTA 
From the Department ofMicrobiology and the Comprehensive Cancer Center, Cellular Immunobiology Unit 
of the Tumor Institute, University of Alabama in Birmingham, Birmingham, Alabama 35294; and the 
Department ofMicrobiology and Immunologr, Washington Unwersity School of Medicine, St. Louis, 
Missouri 63110; and the National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Bethesda, Maryland 20014 
Although it has been clearly demonstrated that antibodies to pneumococcal cap- 
sules are protective in both mice and men (1, 2), the protective properties of antibodies 
to other pneumococcal constituents have been less well investigated. In the present 
report we describe results indicating that naturally occurring antibodies binding with 
the phosphocholine (PC)1 determinant of the pneumococcal cell wall C-carbohydrate 
(3) are important in the protection of mice from experimental pneumococcal infec- 
tions. 
We made this observation while investigating what effects the immune deficiency 
of the CBA/N mouse might have on its susceptibility to pneumoeoccal infection. This 
strain carries an X-linked inability (xid) to produce normal humoral antibody 
responses to a group of thymus independent (TI-2), predominantly carbohydrate 
antigens (4), including type 3 pneumococcal capsular polysaccharide (5), trinitro- 
phenyl-Fieoll (6), PC (7, 8), dextran (9), levan (8), and group A streptococcal 
carbohydrate (10). The CBA/N mouse is probably unable to make high levels of 
anticarbohydrate antibodies in general because the bulk of mouse anticarbohydrate 
antibodies is either IgM or IgGa (11), and CBA/N mice produce low levels of IgM 
(12, 13) and virtually no serum IgGa (13), In other respects, CBA/N mice appear 
immunologically normal because they make relatively normal antibody responses to 
T-dependent antigens (14-16), they have relatively normal levels of the other murine 
immunoglobulin isotypes (13), and they express normal cell-mediated immunity (6). 
By infecting CBA/N mice with various pathogens, it should be possible to determine 
whether anti-carbohydrate antibodies play important roles in defense. Our studies 
have clearly demonstrated that CBA/N mice are highly susceptible to intravenous 
infection with type 3 pneumococci (17), but contrary to our expectations, we have 
found that naturally occurring antibody to PC rather than induced anti-type 3 
* Supported by grants AI-15986, AI-00338, AI-14782, CA-16673, and AI-11635 from the National 
Institutes of Health, Bethesda, Md. 
i Abbrevt~ttions usedin thispaper: BSA, bovine serum albumin; C × D, (CBA/N female × DBA/2 male) F1 
mice; D X C, (DBA/2 female × CBA/N male) FI mice; KLH, keyhole limpet hemocyanin; NAG, fl- 
phenyl-N-acetyl-D-glucosaminide; NMS, normal mouse serum; PBS, phosphate-buffered saline; PC, phos- 
phocholine. 
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BRILES ET AL. 695 
capsular antibody was important for survival. Other investigators have shown that 
CBA/N mice are also especially susceptible to Salmonella typhimurium, Ascaris suum, and 
Plasmodium yoelii (18-20). 
Mater ia l s  and  Methods  
Mice. (CBA/N × DBA/2)F1 (C × D) males and (DBA/2 × CBA/N)F~ (D × C) males were 
obtained from the Rodent and Rabbit Production Unit of the National Institutes of Health, 
Bethesda, Md. BALB/cJ mice were obtained from The Jackson Laboratory, Bar Harbor, 
Maine. 
Bacterial Strains. A human isolate of type 3 pneumococci was obtained courtesy of Mr. John 
Courtney, Washington University School of Medicine. This isolate had been maintained over 
a period of 15 yr by annual passage through mice. After three additional mouse passages, train 
WU1 was established from a smooth colony. From a subsequent mouse passage of WU1, we 
isolated a more virulent subline, WU2. Two additional mouse passages have not increased the 
virulence of WU2. Both sublines were shown to be type 3 by specific antisera. Group A 
streptococcus, J17A4 (21), was obtained from Dr. R. Lancefield, The Rockefeller University. S. 
typhimurium, SR-11 (22), was obtained from Dr. L. J. Berry, The University of Texas at Austin. 
Streptococcus pneumoniae, R36A (23), was obtained from Dr. A. Tomasz, The Rockefeller Univer- 
sity. Listeria monocytogenes, LM-22, was obtained from Dr. D. M¢/Gregor, Cornell University. All 
cultures were stored at -70°C in media (see below), except for S. pneumoniae which was frozen 
in medium plus 10% glycerol. Freshly thawed euhures of L. monocytogenes and S. typhimurium 
were grown in Todd-Hewitt broth (Difco Laboratories, Detroit, Mich.) supplemented with 5% 
yeast extract (Difco Laboratories). Streptococcal nd pneumococcal cultures were grown in the 
same medium supplemented with 0.2% heparinized human blood. Pneumococci for infection 
were grown from a frozen stock as indicated above for ~6-8 h and harvested by centrifugation 
at 4°C while still in log phase. The bacteria were washed once and suspended in Ringers- 
lactate solution. Optical density (OD) at 420 nm was determined (OD of 1 --- 3 × 10 a cocci/ 
ml). The bacteria were kept at 4°C from the time of harvest until injection. Immediately after 
injection, the inoculum was plated on blood agar to determine the number of colony-forming 
units per milliliter, and to examine colony morphology. 
Protection of C × D Males with Normal Mouse Serum (NMS). Pools of NMS were obtained by 
bleeding about 40 8-12-wk-old C X D and D X C males. Harvested NMS was heat inactivated 
at 56°C for 40 min, filter sterilized, and stored at -20°C. About 200 live bacteria were added 
per 0.1 mi of NMS. After 30 min incubation on ice, an equal volume of cold Ringers was 
added, and mice were injected intravenously with 0.2 ml of the mixture. Injections were 
planned so that each cage contained about equal numbers of mice receiving D × C and C × 
D NMS. 
Levels of Anti-PC Antibody m NMS. These values were determined by radioimmunoassay. 
The wells of vinyl microtiter plates (Cooke-Dynatech Laboratories, Inc., Alexandria, Va.) were 
coated overnight with 0.1 ml of PC-bovine serum albumin (BSA) at 10 ~g/ml in phosphate- 
buffered saline (PBS). The PC-BSA was prepared as described elsewhere (24). The wells were 
rinsed, filled with 1% (BSA) in 0.005 M PBS, pH 7.4 (1% BSA-PBS), and allowed to stand for 
3 h at room temperature. A 1:30 dilution of normal serum in 1% BSA-PBS was added to the 
first well and diluted out in subsequent wells with threefold serial dilutions. Plates were allowed 
to stand overnight at 4°C, and rinsed with PBS. Wells were then filled with 0.1 ml of 1% BSA- 
PBS containing 50,000 epm of 125I-labeled goat anti-mouse x antibody (25). After an additional 
overnight incubation at 4°C, the wells were rinsed, cut from plates, and counted in a gamma 
counter. Maximum counts bound to the wells was ~30,000. For each serum we determined the 
dilution binding 15,000 epm of the label. Anti-PC titers could be inhibited with 0.1% 
phosphocholine chloride. By comparing the titers of the normal sera with the titers of samples 
containing known amounts of hybridoma ntibody, we calculated the amount of antibody in 
the NMS. 
Absorption of NMS with Bacteria nd Immunoabsorbents. Bacteria were grown in starter cultures 
as described above and then grown in 500 ml vol of Todd-Hewitt broth plus 0.5% yeast extract 
for 6-12 h. While the cultures were still in log phase, they were killed with formaldehyde (0.2% 
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696 ANTIPHOSPHOCHOLINE ANTIBODIES IN NORMAL MOUSE SERUM 
final concentration, 12-24 h at room temperature) (26). Killed bacteria were harvested by 
centrifugation, washed twice with Ringers olution, once with 1% BSA-PBS, and suspended in
1% BSA-PBS. PC and fl-phenyl-N-acetyl-D-glueosaminide (NAG) immunoabsorbents were 
prepared as described previously (27, 28). NMS were absorbed by adding 6 × l0 s bacteria or 
0.05 ml immunoabsorbent/ml of NMS and rotating at 4°C for 24-36 h. The absorbed sera 
were clarified by centrifugation a d then sterilized by filtration before use. 
Suppression fT-15 Idiotype. The anti-PC response of mice was suppressed by administration 
of monoclonai nti-T-15 antibody derived from the hybridoma GB4-10-4. Details on prepara- 
tion, characterization, and suppressive characteristics of this monoclonal antibody will be 
described elsewhere. Briefly, this hybridoma was derived from a fusion of HOPC-8-immunized 
A/J lymph node cells with the myeloma P3 NS1Ag4-1. The anti-idiotype antibody is yl#¢, its 
binding to T-15 is inhibited by PC-keyhole limpet hemocyanin (KLH) but not by PC and it 
is specific for idiotypic determinants onT-15 and H8 but not two other PC-binding myelomas, 
MOPCI67 and MOPC511. Adult mice were suppressed by four daily injections of 100/xg of 
purified antibody before challenge with pneumococeus. This dose has been shown to inhibit 
both the T-15 idiotype and total anti-PC response (Kearney, Barletta, Quan, and Quintans, 
manuscript in preparation). 
Protection with Hybridoma Antibodies. IgM anti-type 3 hybridomas CA3-1, CC4-8, and DB6 
have been described previously (29). IgM anti-PC hybridoma M2 was obtained from Dr. P. 
Gearhart, Carnegie Institute of Technology. Anti-S. typhimurium hybridoma, ST-1, was obtained 
from P. Basta, University of Alabama in Birmingham. Hybridoma ntibodies from all tumors 
except M2 were raised as ascites in BALB/c mice. The M2 tumor was raised in C × D male 
mice. 
The amount of antibody in these fluids was estimated by determining the total levels of IgM 
(30) in the ascites fluids. The concentrations of antibody in these ascites fluids ranged from 5- 
20 mg/ml. Mice were injected intraperitoneally 1 and 2 d later with 0.1 ml of diluted ascites 
fluid containing 200 gg of hybridoma ntibody 2 h before intravenous inoculation of pneu- 
mococci. Control mice received 0.1 ml of a 1:50 dilution of BALB/cJ NMS. 
Results 
Susceptibility of xid Mice to Type 3 Pneumococci. To examine the effects of the xid 
allele on the susceptibility of mice to pneumococcal infection, we infected the 
reciprocal Fa males obtained by crossing DBA/2 and CBA/N mice. Males derived 
from a CBA/N mother (C × D) express the recessive X-linked immunodeficiency, 
whereas males with a DBA/2 mother (D × C) are normal in their immune respon- 
siveness (6, 12). 
When these mice were infected intravenously, we could easily distinguish between 
xid normal and defective mice (Table I). When the infections were given intraperito- 
neally, even the immunologically "normal" D × C males were highly susceptible, as 
expected (31, 32). We found that C × D males could be killed with ~1,000-10,000 
times fewer type 3 S. pneumoniae pneumococci than D × C males or C × D females. 
TABLE I 
LDso of Pneumococci in xid Normal and Defective Mice 
Pneumococcal Route of infection 
strain 
Mice 
C×D~ C× D~ D×Cd 
WU 1 Intravenous 104. ND~ 107 
WU2 Intravenous 101 105 105 
WU2 Intraperitoneal < 101 101 102 
* LD~0. All deaths occurred between 1and 5 d after infection. 
:~ Not determined. 
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BRILES ET AL. 697 
Many of the C X D males died within 2 d (Fig. 1). It seemed unlikely that the early 
deaths of the C × D males were the result of their inability to respond to the infection 
by the production of antibody, because ven normal mice would not be expected to 
produce appreciable serum levels of antibody within the first 2 d (33, 34). One possible 
explanation was that C × D males lacked "naturally occurring" anticarbohydrate 
antibody cross-reactive with type 3 S. pneumoniae. 
Protection of xid Mice with NMS. To determine whether normal mouse sera are 
protective, we incubated the infecting doses of pneumococci at 0°C with 0.2 ml of 
heat-inactivated NMS from either C X D or D x C male mice. This incubation step 
did not reduce the numbers of viable pneumococci, as determined by growth on blood 
plates. Mice were injected intravenously with 0.2 ml of the incubation mixture and 
injected intraperitoneally with additional 0.2-ml vol of the corresponding normal 
serum at 1 and 2 d after infection. From the data plotted in Fig. 2A and B, it is 
apparent hat even these small amounts of D × C male serum can protect C X D 
males from infection with pneumococcal strains WU 1 and WU2. No protection was 
seen with C × D male serum. 
Specificity of Protective Antipneumococcal Antibody in NMS. To investigate the specificity 
of the protective antibody, we absorbed normal serum with formalin-killed bacteria. 
The results of this study are depicted in Fig. 3A, where it can seen that absorption 
with either the encapsulated strain, WU2, or the nonencapsulated strain, R36A, 
removed most of the protective ability from the serum. Absorption with strain J 17A4 
had a much smaller effect. Because strain R36A is a genetically nonencapsulated type 
2 pneumococcal strain, these data indicate that the protective antibodies in normal 
serum are not directed against the type 3 capsule of the pneumococcus but against 
some other component(s). Because both the WU2 and R36A strains should have PC 
in their cell walls (3), we suspected that the protective antibody might be directed 
against his determinant. As expected, pooled normal sera from C × D male mice had 
much lower levels of anti-PC antibody than sera from C × D females or D × C males 
(Table II) (35). The anti-PC antibody in D × C male sera was in fact largely removed 
by absorption with both of the pneumococcal strains. The significance of the residual 
A 
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2O 
i J t//.J 
I 2 3 4 5 6 7 I0 
B I 001~ _ ~  : = = 
80 ~ \ DxC~ :':~" 
4060f /Cx  D 2 0  ~ 200 WU2 
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Doys Posl-infection 
Fro. 1. Susceptibility of D X C and C X D males to type 3 S. pneumoniae. Mice were infected 
intravenously with either 105 WUI (A) or 200 WU2 (B) on day 0. Each group contained 10 or more 
mice. 
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698 ANTIPHOSPHOCHOLINE ANTIBODIES IN NORMAL MOUSE SERUM 
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Fio. 2. Protection of C X D males with NMS. Mice were infected intravenously with either 105 
WUI (A) or 200 WU2 (B) in 0.2 ml of heat-inactivated C x D male or D x C male NMS on day 
0. The bacteria were incubated with the NMS for 30 min at 0°C before infection. Each group 
contained 10 or more mice. 
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Fro. 3. Protection of  C x D males with absorbed D X C male NMS. Preliminary experiments 
indicated that 1 -20D U (420 nm) of formalized strain WU2 S. pneumoniae were required to absorb 
out most of the protective activity of 1 ml ofD X C male serum. In these xperiments, D × C serum 
was absorbed with 20D U/ml (109) killed bacteria (A) or 0.05 ml of immunoabsorbent (B) per 
milliliter of NMS. Live WU2 bacteria were then incubated in the absorbed NMS before injection 
as in Fig. 2. Bacteria used for absorption were WU2, type 3 S. pneumoniae, R36A, nonencapsulated 
(rough) S. pneumoniae, and J 174A, group A streptococci. Immunoabsorbents used PCoSepharose and 
fl-phenyl-N-acetyt-o-glucosaminide-Sepharose. E ch group contains nine or more mice. Significant 
differences from "none" at <0.03 and <0.01 are indicated by * and **, respectively. 
anti-PC antibody is unclear. It may be due to low affinity antibody because it is not 
absorbed out by an excess of bacteria. The anti-PC antibody was only partially 
absorbed by group A streptococci. This partial absorption by group A streptococci 
correlates with the fact that this strain also partially removed protection from D × C 
male sera. 
To determine whether the protective antibodies in normal sera were directed 
against PC, we absorbed D × C male serum with a PC-containing immunoabsorbent. 
As a control, the sera were absorbed with an immunoabsorbent containing NAG, the 
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BRILES ET AL. 
TABL~ II 
Titers of Anti-PC Antibody in NMS 
Anti-PC 
Serum pool titer* 
C x D male 6 
C × D female 106 
D X C male 113 
C × D male 
C × D male 
D × C male 
D × C male 
Inhibitor$ 
0.1% PC 10 
0.1% Rhamnose 11 
0.1% PC 3 
0.1% Rhamnose 96 
Absorbent§ 
3.0 × 109 WU2 26 
1.0 x 10 s WU2 25 
0.33 × 109 WU2 29 
0.1 × 109 WU2 61 
1.0 × 109 R36A 25 
1,0 × 10aJI7A4 72 
1.0 × 109 Listeria 110 
PC-Sepharose 33 
NAG-Sepharose 107 
D × C male 
D × C male 
D × C male 
D × C male 
D × C male 
D × C male 
D × C male 
D × C male 
D × C male 
699 
* Dilution of antisera binding 50% of labeled anti-• (see Materials and 
Methods). Each value is an average of two or more determinations. By using 
anti-PC hybridoma M2 as a standard, the concentrations of anti-PC antibody 
in C X D male, C X D female, and D X C male sera are 15, 258, and 265 
ng/ml. 
$ Normal mouse sera were titered out in the indicated inhibitors diluted in 1% 
BSA-PBS. 
§ Absorptions were done as described in Fig. 2. Numbers of bacteria for 
absorption were determined from the OD 420 nm of washed bacteria. 
immunodominant  group of  streptococcal  group A carbohydrate.  The  results shown in 
F igure 3B indicate that only  the PC immunoabsorbent  removed the protect ive abil ity. 
Thus  it appears l ikely that  ant i -PC ant ibodies in normal  sera play an impor tant  role 
in the resistance of  mice to pneumococca i  infection. 
Pneumococcal Susceptibility of Mice Whose Anti-PC Antibody Response Has Been Sup- 
pressed. Because of  the unexpected  nature  of  the above observations, we sought to 
determine  by a complete ly  different method  whether  ant i -PC ant ibodies were in fact 
essential for protect ion against pneumococca l  infection. Most  ant i -PC ant ibodies in 
BALB/c  mice bear  a common idiotype, T-15 (36, 37). It has been shown previously 
that,  in the adult ,  passive admin is t rat ion  of  ant ibodies react ive with the T-15 id iotype 
can suppress the product ion  o f  most ant i -PC ant ibodies (38, 39) wi thout  affect ing 
responsiveness to other  antigens. Thus,  we used the ant i -T-15 hybr idoma,  GB4-10-4 
(71,x), to suppress the ant i -PC responses of  BALB/c  mice. The  dose of  GB4-10-4 used 
has been shown to block induced ant i -PC  responses in BALB/c  mice (Kearney,  
Barletta,  Quan,  and Quintans ,  manuscr ipt  in preparat ion)  and in this study reduced 
the levels Of natura l ly  occurr ing ant i -PC ant ibody to <1/3  of  normal  levels. These 
mice were infected with 5 × 103 WU2,  a dose not normal ly  fatal to BALB/c  mice. As 
can be seen in Fig. 4, most of  the suppressed mice and none of  the control  mice died 
of  pneumococca l  infection. 
Protection of xid Mice with Hybridoma Antibodies. Final ly,  we examined  the abi l i ty of  
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FIG. 4. Effect o f  anti -PC suppression on the resistance of  BALB/c J  mice to S. #neumoniae. Ant i -PC 
ant ibody production was suppressed by intraperitoneal injection o f  100/~g/d o f  GB4-10-4 anti-T-15 
hybridoma. After a week of daily injections, mice were rested 6 d, bled on day 7, and infected 
intravenously on day 8 with 5 × l0 s WU2. Each group contained eight mice. 
A 
anti  - PC  ,w, IOC= ,= = = = .; :. = ,'14 
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B 
IO0(~D~l~ 5000 WU2 :;F\  sss.= 
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FIG. 5. Protection of C X D males with passive antibody. Mice were injected intraperitoneally 
with 0.1 ml of diluted hybridoma-containing as, cites fluid or 1:50 BALB/cJ NMS (none) 2 h before 
and 1 and 2 d after intravenous injection of 200 (A) or 5,000 (B) viable WU2. In B, each group 
contained eight or more mice. In A, the numbers of mice per group were 7 anti-PC; 15 anti-SSS-III; 
4 anti-Salmonella; nd 7 NMS. Significant difference from "none" at P <0.03 or P <0.01 is 
indicated by * or **, respectively. 
IgM hybr idoma antibodies to either type 3 polysaccharide, PC, or S. typhimurium to 
protect C X D males from pneumococcal infection. Mice were injected intraperito- 
neally with 200/xg of hybr idoma nt ibody in 0.1 ml of di luted aseitic fluid 2 h before 
inoculation with either 200 or 5,000 colony-forming units of strain WU-2,  S. pneumoniae 
(Fig. 5). To conti"ol for possible protection by natural ly  occurring ant ipneumoeoccal  
antibodies in the ascitic fluids, we injected a group of mice with a comparable di lution 
(1:50) of BALB/c  NMS (Fig. 5). To further exclude the possibil ity that any protection 
obtained with the ant i -PC hybr idoma might be due to natural ly occurring ant ibody, 
the M2-containing ascitic fluid was obtained from C X D male mice carrying the 
tumor. 
The results of these experiments demonstrated that the ant i -PC hybr idoma, M2, 
and the three IgM anti-type 3 hybridomas, CA3-1, CC4-8, and DB6, all gave 
protection. The three ant i - type 3 hybr idomas mediated similar levels of protection, 
and their pooled data are depicted. Protection was also observed with isolated M2 
and CC4-8 (data not shown). The anti -Salmonel la hybr idoma showed significantly 
less protection. Although we do not yet know the min imum amounts of hybr idoma 
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BRILES ET AL. 701 
antibody required, it is now clear that as little as 20 #g/d of M2 and CA3-1 antibody 
can provide complete protection. 
Discussion 
In these studies we used immunodeficient xid mice to examine the importance of 
anticarbohydrate antibody in the defense of mice against pneumococcal infection. 
We expected C × D male mice to be highly susceptible to pneumococca! infection 
because they are unable to make antibodies to the capsule of the type 3 pneumococcus 
(5), and earlier eports had indicated that anticapsular antibodies were important for 
protection against pneumococcal infection (1, 31, 40). We were quite surprised when 
our results demonstrated that not only do antibodies in normal serum offer significant 
protection against pneumococcal infection, but these normal serum antibodies are 
reactive with the PC determinant of the cell wall rather than with the capsule. 
We do not feel that our results negate any of the studies howing that anticapsular 
antibody is highly effective in the defense against pneumococcal infection. On the 
contrary, the role of anti-PC antibody may account for some of the nonspecific 
immunity to pneumococci (41, 42) and may delay the infection until protective l vels 
of anticapsular antibody are generated. 
If anti-PC antibodies do play an important role in the defense against pneumococci 
or other pathogens, it might explain in part why anti-PC antibodies how such 
extreme homogeneity oftheir specificity (43), idiotype (36, 44), and structure (45-47). 
The naturally occurring anti-PC antibodies we find in normal sera are probably 
the result of immunostimulation with PC-containing environmental ntigens. PC has 
been found on the surface of many microbes, including a number of different bacteria, 
fungi, and nematodes (48, 49). Naturally occurring anti-PC antibodies are commonly 
found in sera of mouse strains (35) other than CBA/N and are easily demonstrable in 
normal human sera (D. E. Briles and C. Forman, unpublished observations). The 
existence of anti-C carbohydrate antibody in human sera has been established 
previously (50). 
There may be several reasons why protection with anti-PC antibody has not been 
reported before. Isolated C carbohydrate is poorly immunogenic (51), and even when 
an anti-PC response was induced, it may not have always raised the levels of anti-PC 
antibody sufficiently higher than the naturally occurring levels to cause a marked 
difference in protection. Furthermore, the early and dramatic successes of raising 
type-specific protective antibody to isolated pneumococcal capsules (1, 40) probably 
reduced interest in studies of protective antibodies to pneumococcal ntigens other 
than capsular polysaeeharides. 
Although we know of no previous reports indicating that anti-PC antibodies are 
protective against pneumococcal infection, the older literature does contain several 
reports of immunizations with whole bacteria (52, 53) or bacterial fractions that 
yielded protection in rabbits across type barriers (54-56). The protection could be 
transferred with serum to other abbits but not to mice (52). More recently, Thompson 
and Eisenstein (57) have shown that a vaccine composed of a subcellular preparation 
of rough type 3 pneumococci ould protect mice from infection with encapsulated 
types 1, 2, or 3 pneumococci. It seems likely that at least some of these reports dealt 
with the effects of anti-PC antibody. 
One of the most compelling findings was that of Dubos (58), who reported that if 
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autolysates of rough or smooth pneumococci were injected into rabbits, antisera could 
be produced that could protect mice against pneumococci regardless of their capsular 
type. Neither the nature of the antigen that induced these antibodies nor the antibody 
specificity was reported. However, it was known that autolysates of pneumococci 
contain C carbohydrate (59), and more recently it has been shown that PC is a major 
antigenic determinant of C carbohydrate (60). Choline has also been shown to be 
present in pneumococcal F antigen (61). 
The fact that anti-PC antibodies are protective against encapsulated type 3 
pneumococci is particularly interesting because all strains of S. pneumoniae have C 
carbohydrate in their cell walls (3, 51). 
Summary  
The antiphosphocholine (PC) antibody in normal mouse sera (NMS) provides 
protection against intravenous infection with encapsulated strain WU2 of type 3 
Streptococcus pneumoniae. Mice unable to mak~ anti-PC antibody, as a result of suppres- 
sion with anti-T-15 idiotype or inheritance of the xid gene of CBA/N mice, are highly 
susceptible to infection with strain WU2. Mice inheriting the xid gene can be protected 
with NMS from immunologically normal mice or with IgM hybridoma anti-PC 
antibody. The protective ffect of NMS can be removed with PC-containing immu- 
noabsorbents. 
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time from their own studies to provide advice, encouragement, and assistance during the course 
of these experiments. We are particularly grateful for suggestions and encouragement from Dr. 
John Robbins. 
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